Viewing Study NCT05424003


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-02-23 @ 8:06 PM
Study NCT ID: NCT05424003
Status: RECRUITING
Last Update Posted: 2025-07-03
First Post: 2022-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
Sponsor: Virginia Commonwealth University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-02-22
Start Date Type: ACTUAL
Primary Completion Date: 2026-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-02
Completion Date Type: ESTIMATED
First Submit Date: 2022-06-14
First Submit QC Date: None
Study First Post Date: 2022-06-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-02
Last Update Post Date: 2025-07-03
Last Update Post Date Type: ACTUAL